Overview

Role of Volatile Anesthetics for Hepatic Protection

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
0
Participant gender:
All
Summary
This study aims to evaluate the attenuation of ischemic-reperfusion injury in the liver after sevoflurane preconditioning. In the presence of sevoflurane, an attenuation of liver injury is hypothesized (diminished increase of liver enzymes, reduced production of inflammatory mediators).
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Zurich
Treatments:
Anesthetics
Sevoflurane
Criteria
Inclusion Criteria:

- Older than 18 years of age

- Patients undergoing liver resection (benign or malignant tumors)

Exclusion Criteria:

- Laparoscopic liver resection coagulopathy (platelets < 50,000/ml, Quick < 50%)

- Liver cirrhosis